- Home
- OIS vs TRML Comparison
OIS vs TRML Comparison
Compare OIS & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- TRML
- Stock Information
- Founded
- OIS 1995
- TRML 2021
- Country
- OIS United States
- TRML United States
- Employees
- OIS N/A
- TRML N/A
- Industry
- OIS Metal Fabrications
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- TRML Health Care
- Exchange
- OIS Nasdaq
- TRML Nasdaq
- Market Cap
- OIS 353.2M
- TRML 419.1M
- IPO Year
- OIS 2001
- TRML N/A
- Fundamental
- Price
- OIS $5.42
- TRML $22.72
- Analyst Decision
- OIS Buy
- TRML Strong Buy
- Analyst Count
- OIS 3
- TRML 3
- Target Price
- OIS $6.50
- TRML $65.00
- AVG Volume (30 Days)
- OIS 651.0K
- TRML 179.1K
- Earning Date
- OIS 10-30-2024
- TRML 11-07-2024
- Dividend Yield
- OIS N/A
- TRML N/A
- EPS Growth
- OIS N/A
- TRML N/A
- EPS
- OIS N/A
- TRML N/A
- Revenue
- OIS $736,259,000.00
- TRML N/A
- Revenue This Year
- OIS N/A
- TRML N/A
- Revenue Next Year
- OIS N/A
- TRML N/A
- P/E Ratio
- OIS N/A
- TRML N/A
- Revenue Growth
- OIS N/A
- TRML N/A
- 52 Week Low
- OIS $3.91
- TRML $12.12
- 52 Week High
- OIS $7.27
- TRML $48.31
- Technical
- Relative Strength Index (RSI)
- OIS 62.16
- TRML 35.49
- Support Level
- OIS $5.22
- TRML $25.58
- Resistance Level
- OIS $5.46
- TRML $27.51
- Average True Range (ATR)
- OIS 0.20
- TRML 1.80
- MACD
- OIS 0.03
- TRML -0.62
- Stochastic Oscillator
- OIS 80.00
- TRML 2.12
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore/Manufactured Products, Well Site Services and Downhole Technologies. It erns maximum revenue from Offshore/Manufactured Products.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.